Feasibility of Allogeneic Hematopoietic Cell Transplantation Among High-Risk AML Patients in First Complete Remission: Results of the Transplant Objective from the SWOG (S1203) Randomized Phase III Study of Induction Therapy Using Standard 7+3 Therapy or Idarubicin with High-Dose Cytarabine (IA) Versus IA Plus Vorinostat

著录项

• 来源
  《Blood: The Journal of the American Society of Hematology》 |2016年第22期|共6页
• 作者

  Pagel John M.; Othus Megan; Garcia-Manero Guillermo; Fang Min; Radich Jerald P.; Rizzieri David A.; Marcucci Guido; Strickland Stephen A.; Litzow Mark; Savoie Mary Lynn; Spellman Stephen R.; Confer Dennis L.; Chell Jeffrey; Brown Maria; Medeiros Bruno C.; Sekeres Mikkael A.; Lin Tara L.; Uy Geoffrey L.; Powell Bayard L.; Kolitz Jonathan E.; Larson Richard A.; Stone Richard M.; Claxton David F.; Essell James; Luger Selina; Mohan Sanjay R.; Moseley Anna; Erba Harry P.; Appelbaum Frederick R.;

  展开▼
• 作者单位

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类
• 关键词